Inhibition of proteasome‐dependent degradation of Wee1 in G<sub>2</sub>‐arrested Hep3B cells by TGFβ1

Osamu Hashimoto(Gifu University), Michio Sata(Kurume University), Sanae Uchida(Kanazawa University), Takato Ueno(Kurume University), Motoaki Ohtsubo(Memorial Sloan Kettering Cancer Center), Takuji Torimura(Omuta hospital), Toru Nakamura(Hokkaido University), Rina Kimura(Hokkaido University), Katsumi Yamashita, Hironori Koga(Kurume University)
Molecular Carcinogenesis
March 26, 2003
10.1002/mc.10111
Cited by 45

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504